Canada: Health Canada Proposes New Regulatory Pathway For "Cannabis Health Products"

Last Updated: July 16 2019
Article by Jeremy Burke and Vernon Lin

On June 19, 2019, Health Canada released a document titled Consultation on Potential Market for Cannabis Health Products that would not Require Practitioner Oversight (the “Consultation Paper”). The document canvasses Health Canada’s plans to create a new regulatory pathway for Cannabis Health Products (“CHPs”) in the context of seeking public and industry input on this proposed new branch of Canada’s cannabis regulatory regime.

What is a CHP?

Health Canada proposes to define CHPs as drugs containing cannabis that make health claims regarding treatment of “minor ailments.” A “drug containing cannabis” is just a cannabis product that is marketed with a therapeutic claim. To paraphrase the Cannabis Regulations, this is a claim that the cannabis product prevents or treats a disease or abnormal state, or modifies an organic function in human beings.

The proposed CHP regime would capture drugs containing any cannabinoid, or other ingredient that currently comprises cannabis pursuant to Schedule 1 of the Cannabis Act. Accordingly, it appears that the much desired de-scheduling of cannabidiol (CBD) is not yet on the table for the federal government.

It is useful to note that by definition, a “drug containing cannabis” and “cannabis products” for medical purposes differ (in the Cannabis Regulations) only because the former can be marketed with a(n explicit) therapeutic claim, and the latter cannot.

Where will CHPs be sold?

Currently, under the Cannabis Act and the Food and Drugs Act (“FDA”), any drug containing cannabis can only be sold to consumers with health practitioner oversight pursuant to a doctor’s prescription – just like any other prescription pharmaceutical drug (e.g. through a pharmacy). Cannabis products for medical purposes, on the other hand, can be sold only by holders of a federal Cannabis Act licence for medical sale to consumers who have provided the required medical document (akin to a prescription).

Under the proposed new framework, CHPs would be available to consumers through the same retail channels as recreational cannabis products (i.e., provincially-authorized retailers) and also from holders of a federal licence for medical sale – but without the requirement for a medical document.

This will be welcome news to medical sale licence holders who otherwise would be facing the creation of a new class of health-oriented cannabis products that they could not sell. This element of the proposed CHP regime may also encourage new federal medical sale licence applications by retail chains (e.g. pharmacies and health stores), some of whom may have been reticent to join a medical cannabis retail market focused on selling smokeables.

Federal medical sale licence-holders and provincially-authorized retailers selling CHPs would be subject to the same restrictions that apply to the current sale of medical or recreational cannabis products, including restrictions on promotions that may be appealing to young persons, etc.

Health Canada indicates that young persons would be protected from unrestricted use of CHPs by the imposition of a requirement that CHPs only be accessed through a responsible adult. The obvious implication is that minors will not be permitted to purchase CHPs, but it may be that the government will seek to impose additional statutory responsibilities on adults who purchase CHPs for ultimate use by children under their care. Such responsibilities could include, for example, a duty to act responsibly and in the child’s best interests before facilitating the use of a CHP by a minor.

It will be disappointing to some, but not surprising, that CHPs are not proposed to be sold alongside licensed Natural Health Products in any retail location. Such open retail channels are an unlikely prospect for any product containing THC and, accordingly, also for CBD-only products until the regulatory regime differentiates between the two.

Who will manufacture CHPs?

The Consultation Paper does not specify what Health Canada-issued licences would have to be held by CHP manufacturers. Given that Health Canada intends to rely on the FDA framework for health claims and other requirements, it seems likely that CHPs would, like other drugs containing cannabis, be manufactured only by holders of a Cannabis Drug Licence (issued under the Cannabis Act) and a Drug Establishment Licence (issued under the FDA).

CHP manufacturers would not be able to make general health claims (e.g. related to general health maintenance or promotion) and any specific claims would need to be backed by scientific evidence. Like other drugs containing cannabis, CHPs would be subject to a pre-market review by Health Canada to determine whether health claims made and the safety, efficacy and quality of the product are supported by scientific evidence. CHP packaging/labelling would also undergo a pre-market review and would have to include dosing information, directions for product use, listing of ingredients and any warnings of potential side effects.

Consultation Timeline

Though arguably a welcome baby step in the right direction, this Cannabis Health Product initiative will feel like more of the same to most Canadians and other cannabis industry stakeholders, as it does not differentiate between THC and non-psychoactive cannabinoids like CBD. Instructions on how to provide feedback to Health Canada on the Consultation Paper (before consultation closes on September 3) can be found here.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
Similar Articles
Relevancy Powered by MondaqAI
 
In association with
Related Topics
 
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
 
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Mondaq Free Registration
Gain access to Mondaq global archive of over 375,000 articles covering 200 countries with a personalised News Alert and automatic login on this device.
Mondaq News Alert (some suggested topics and region)
Select Topics
Registration (please scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.

Disclaimer

The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.

General

Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions